Robert G. Petit
Chief Tech/Sci/R&D Officer at OS Therapies, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nikolai Kley | M | - |
Orionis Biosciences, Inc.
 Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 9 years |
| Paul Romness | M | 57 |
OS Therapies, Inc.
 OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 6 years |
| Alan Musso | M | 62 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 1 years |
| Jan Tavernier | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | - |
| James N. Kyranos | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 8 years |
| Colin Goddard | M | 64 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 4 years |
| Matias de Tezanos | M | 44 |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 6 years |
| Steve Gullans | M | 71 |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | - |
| Joacim Borg | M | 32 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 2 years |
| Griet Vanpoucke | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 9 years |
| Matias de Tezanos | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 6 years |
| Theodore F. Search | M | 42 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 4 years |
| John Ciccio | M | 43 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 4 years |
| Tim Power | M | - | 18 years | |
| William Perhacs | M | - | 17 years | |
| Jack Doll | M | - |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter R. Dolan | M | 68 | 18 years | |
| James Cornelius | M | 81 | 10 years | |
| Togo Dennis West | M | 81 | 10 years | |
| John Tsai | M | 57 | 11 years | |
| Gerald Bruce | M | 68 | 8 years | |
| Vicki Sato | M | 75 | 15 years | |
| David J. Helfgott | M | - | - | |
| Louis Gerstner | M | - | - | |
| Alan J. Lacy | M | 70 | 12 years | |
| Michael Grobstein | M | 81 | 13 years | |
| James Robinson | M | 88 | 29 years | |
| Carl Decicco | M | 62 | 10 years | |
| Louis J. Freeh | M | 74 | 8 years | |
| Robert Williams | M | 75 | 7 years | |
| Douglas Manion | M | 64 | 11 years | |
| Xiaolin Liu | M | - | 2 years | |
| Douglas Hay | M | - | 6 years | |
| Thomas Gibbs | M | 52 | 5 years | |
| Jon Wigginton | M | 62 | 5 years | |
| Dieter Weinand | M | 63 | 9 years | |
| Christopher Bowden | M | 63 | 3 years | |
| Annalisa Jenkins | M | 58 | 2 years | |
| John Golubieski | M | 59 | 16 years | |
| James Patrick McDermott | M | - | 3 years | |
| Dean Hakanson | M | 72 | 1 years | |
| Sheila Gujrathi | M | 53 | 3 years | |
| Elizabeth Yamashita | F | - | 6 years | |
| Pankaj Mohan | M | 60 | 2 years | |
| Lena Elisabeth Svanberg | M | 63 | 7 years | |
| Karen Smith | M | 56 | 5 years | |
| Ramy Ibrahim | M | 49 | 6 years | |
| Edward Berg | M | - | 2 years | |
| Debora Barton | M | 48 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | 3 years |
| David Wishart | M | - | 10 years | |
| Qin Xia | F | 56 | 1 years | |
| Yadagiri R Pendri | M | 68 | 7 years | |
| David Cohen | M | - | 8 years | |
| Kevin McManus | M | - | 9 years | |
| Michael Williams | M | - | 1 years | |
| David Berman | M | - | 10 years | |
| Mary Kay Turner | F | - | 6 years | |
| St John McGrath | M | - | 3 years | |
| Scott Gunther | M | 57 | 4 years | |
| Cheryl Capps | F | 62 | 13 years | |
| Ronald Cooper | M | 61 | 7 years | |
| Michael Castagna | M | 47 | 2 years | |
| Fu-Min Su | M | - | 6 years | |
| Mark Trudeau | M | 62 | 11 years | |
| Axel Hoos | M | 54 | 6 years | |
| Mark Prudenti | M | - | 2 years | |
| Donald Hayden | M | 68 | 25 years | |
| Vance D. Coffman | M | 79 | 9 years | |
| Louis Sullivan | M | 90 | - | |
| Ellen Futter | F | 74 | 6 years | |
| Stuart Tross | M | 57 | 8 years | |
| Kenneth Bahrt | M | 71 | 3 years | |
| Eleanor Ramos | M | 67 | 2 years | |
| Richard K. Willard | M | 75 | 2 years | |
| Lynn H. Clark | F | 66 | 8 years | |
| Freda Lewis-Hall | M | 69 | 5 years | |
| Geoffrey Gilmore | M | 58 | 11 years | |
| Andrew Shenker | M | 69 | 5 years | |
| John L. McGoldrick | M | 83 | 10 years | |
| Wendy Dixon | M | 68 | 8 years | |
| Jeremy Levin | M | 70 | 5 years | |
| Tamar Howson | F | 75 | 6 years | |
| Daphne Quimi | F | 58 | 2 years | |
| Valerie Sharice Grant | F | - | 3 years | |
| Richard Colonno | M | 74 | 16 years | |
| Mark Altmeyer | M | 63 | 2 years | |
| Laurie Alsup | M | 70 | 10 years | |
| Stephen E. Bear | M | 73 | 7 years | |
| Pablo Lapuerta | M | 60 | 1 years | |
| Matthew Ros | M | 57 | 17 years | |
| Robert Martell | M | 61 | 3 years | |
| Andrew Bonfield | M | 61 | 5 years | |
| William Sharbaugh | M | 61 | 6 years | |
| Roger Theodoredis | M | 65 | 3 years | |
| Lubor Gaal | M | 56 | 9 years | |
| Scott McCallister | M | 62 | 1 years | |
| John P. Amos | M | 57 | 2 years | |
| Blaine Davis | M | 50 | - | |
| R. Jean-Marc Sidney Huët | M | 55 | 1 years | |
| Quentin Roach | M | 57 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert G. Petit
- Personal Network
